Valence 로고
인기
로그인
Loading data for RCKT — first visit, this takes a few seconds.

관심목록에 추가

Rocket Pharmaceuticals In...

NasdaqGM: RCKT · 실시간 가격 · USD
3.34
-0.06 (-1.76%)
종가 기준: Aug 19, 2026, 8:00 PM
3.60
-1.36%
애프터마켓: 4:45 PM

Rocket Pharmaceuticals Inc. (RCKT) Stock Price, Analysis & Data

-1.76%

데이터 없음

매수호가2.95
시가총액400.68M
매출 (ttm)n/a
순이익 (ttm)-17.25M
베타0.47
EPS (ttm)-0.17
P/E (ttm)n/a
선행 P/E-2.8
P/B (ttm)1.67
P/S (ttm)n/a
Earnings DateNov 5, 2026
매도호가4.02
거래량1,081,172
평균 거래량 (20일)2,287,685
시가3.33
전일 종가3.40
일중 범위3.27 - 3.42
52주 범위2.53 - 5.45
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

RCKT 소개

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), whic...

[더 보기]
산업 Biotechnology
섹터 Healthcare
IPO 일자 Feb 18, 2015
직원 수 202
상장 거래소 NasdaqGM
티커 RCKT
웹사이트 https://www.rocketpharma.com
전체 기업 정보

재무 실적

2025년 Rocket Pharmaceuticals의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -223.12M로, -13.77% 감소했습니다.

재무제표

어닝 서프라이즈

Rocket Pharmaceuticals가 Aug 10, 2026에 분기 실적을 발표했습니다:
  • 매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.
  • EPS -0.38 예상치 하회 -0.65, 및 35.59% 전년 대비 성장.

    • 다음 실적 발표

    Rocket Pharmaceuticals Inc.의 실적 발표 예정일은 Nov 5, 2026, 정규장 중입니다.
    애널리스트 예상 매출은 ... 업그레이드
    news image

    1주 전 · Zacks

    Rocket Pharmaceuticals Q2 Earnings Rise Y/Y, Kresladi Launch in Focus

    RCKT records earnings growth in the second quarter. Kresladi launch preparations advance and RP-A501 safety findings support its next development steps.

    news image

    1주 전 · MT Newswires

    Rocket Pharmaceuticals' Danon, PKP2-ACM Updates Seen as Key H2 Catalysts, Wedbush Says

    Rocket Pharmaceuticals' (RCKT) Q2 update confirmed its programs are on track, with management expect

    news image

    1개월 전 · Insider Monkey

    Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone?

    We recently compiled a list of the 10 Most Promising Small-Cap Stocks to Buy According to Hedge Funds. Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) is one of the most promising stocks on our list. TheFl...

    news image

    3개월 전 · Insider Monkey

    Rocket Pharmaceuticals Inc (RCKT) Got Cash. Where’s the Stock Going?

    Rocket Pharmaceuticals Inc (NASDAQ:RCKT) is one of the best gene therapy stocks to buy in 2026. The Street expects Rocket Pharmaceuticals’ stock to explode 180% over the next 12 months. On April 28, L...

    news image

    3개월 전 · Insider Monkey

    Rocket Pharmaceuticals (RCKT) Reports Q1 2026 Net Loss of $47.6M

    Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy right now. On May 7, Rocket Pharmaceuticals reported a Q1 2026 net loss of $47.6 million ($0.42 per share). D...

    2 페이지 중 1